US Edition
Published • loading... • Updated
Sagar Bapat gets 2026 Pathway to Stop Diabetes Award
Summary by The American Bazaar
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Sagar Bapat gets 2026 Pathway to Stop Diabetes Award
Sagar Bapat, an Indian American researcher developing a novel type of living T cell-based therapy to tackle obesity-induced diabetes, has won a 2026 Pathway to Stop Diabetes Award from the American Diabetes Association. Bapat, an Assistant Professor at University of California, San Francisco, is developing a novel T cell therapy to enhance thermogenic function of adipose tissue, seeking to harness targeted cellular therapy and CRISPR technology …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
